Correlation Between Hookipa Pharma and Gossamer Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Gossamer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Gossamer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Gossamer Bio, you can compare the effects of market volatilities on Hookipa Pharma and Gossamer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Gossamer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Gossamer Bio.

Diversification Opportunities for Hookipa Pharma and Gossamer Bio

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Hookipa and Gossamer is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Gossamer Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gossamer Bio and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Gossamer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gossamer Bio has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Gossamer Bio go up and down completely randomly.

Pair Corralation between Hookipa Pharma and Gossamer Bio

Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Gossamer Bio. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.78 times less risky than Gossamer Bio. The stock trades about -0.22 of its potential returns per unit of risk. The Gossamer Bio is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  70.00  in Gossamer Bio on September 27, 2024 and sell it today you would earn a total of  14.00  from holding Gossamer Bio or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Hookipa Pharma  vs.  Gossamer Bio

 Performance 
       Timeline  
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Gossamer Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gossamer Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Hookipa Pharma and Gossamer Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hookipa Pharma and Gossamer Bio

The main advantage of trading using opposite Hookipa Pharma and Gossamer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Gossamer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will offset losses from the drop in Gossamer Bio's long position.
The idea behind Hookipa Pharma and Gossamer Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios